Biotechnology Fund is a registered fund series of Rydex Variable Trust (series S000003711). Net assets $10.7M as of 2026-03-31.
Showing 15 of 200 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| AbbVie Inc. | ABBV | $796K | 746.30% |
| AbbVie Inc. | — | $796K | 746.30% |
| AbbVie Inc. | ABBV | $796K | 746.30% |
| Amgen Inc. | AMGN | $564K | 528.31% |
| Amgen Inc. | AMGN | $564K | 528.31% |
| Amgen Inc. | — | $564K | 528.31% |
| Gilead Sciences Inc. | GILD | $534K | 500.31% |
| Gilead Sciences Inc. | — | $534K | 500.31% |
| Gilead Sciences Inc. | GILD | $534K | 500.31% |
| Vertex Pharmaceuticals Incorporated | — | $431K | 404.31% |
| Vertex Pharmaceuticals Incorporated | VRTX | $431K | 404.31% |
| Vertex Pharmaceuticals Incorporated | VRTX | $431K | 404.31% |
| Regeneron Pharmaceuticals, Inc. | — | $383K | 359.20% |
| Regeneron Pharmaceuticals, Inc. | REGN | $383K | 359.20% |
| Regeneron Pharmaceuticals, Inc. | REGN | $383K | 359.20% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $10.7M |
| 2025-12-31 | $11.7M |
| 2025-09-30 | $9.8M |
| 2025-06-30 | $9.0M |
| 2025-03-31 | $9.4M |
| 2024-12-31 | $10.0M |
| 2024-09-30 | $11.0M |
| 2024-06-30 | $11.0M |